Recruiting NCT06929442
This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.
In United States Schizophrenia, Anxiety Behavioral From 18 Years to 30 Years
Countries United States
Sponsor Massachusetts General Hospital
Condition Schizophrenia, Anxiety Recruiting NCT05081596
This study is recruiting in the United States. It focuses on depression.
In United States Depression Behavioral Over 60 Years
Countries United States
Sponsor Weill Medical College of Cornell University
Condition Depression Recruiting NCT03887715
This study is recruiting in the United States. It is testing VNS Therapy® System for depression.
In United States Depression Device i A study involving a tool, app, wearable, test, or medical device. Over 18 Years
Countries United States
Sponsor LivaNova
Condition Depression Recruiting NCT06906939
This study is recruiting in the United States. It focuses on depression.
In United States Depression Behavioral From 50 Years to 95 Years
Countries United States
Sponsor University of California, Los Angeles
Condition Depression Recruiting NCT07172516
This study is recruiting in the United States. It is testing azetukalner for depression in bipolarity.
In United States Bipolarity, Depression Drug i A study involving a medication or substance. From 18 Years to 74 Years
Countries United States
Sponsor Xenon Pharmaceuticals Inc.
Condition Bipolarity, Depression Recruiting NCT06775379
This study is recruiting in the United States. It is testing azetukalner for depression.
In United States Depression Drug From 18 Years to 74 Years
Countries United States
Sponsor Xenon Pharmaceuticals Inc.
Condition Depression Recruiting NCT07076407
This study is recruiting in the United States, in Finland, in Poland, .... It is testing azetukalner for depression.
In United States Depression Drug From 18 Years to 74 Years
Countries United States, Finland, Poland, ...
Sponsor Xenon Pharmaceuticals Inc.
Condition Depression Recruiting NCT05215353
This study is recruiting. It focuses on anxiety and currently lists participation information in the United States.
In United States Anxiety Behavioral Over 18 Years
Countries United States
Sponsor Memorial Sloan Kettering Cancer Center
Condition Anxiety Recruiting NCT07226895
This study is recruiting in the United States. It focuses on Schizophrenia.
In United States Schizophrenia Drug From 17 Years to 30 Years
Countries United States
Sponsor Monument Therapeutics Limited
Condition Schizophrenia Recruiting NCT06793397
This study is recruiting in the United States, in Australia, in the United Kingdom, .... It is testing a Deuterated Psilocin Analog for depression.
In United States Depression Behavioral From 18 Years to 85 Years
Countries United States, Australia, United Kingdom, ...
Sponsor Cybin IRL Limited
Condition Depression Recruiting NCT07218250
This study is recruiting in the United States. It is testing a One-Time Counseling Session to Help Reduce Depression, Anxiety, and Distress for depression.
In United States Anxiety, Depression Behavioral Over 18 Years
Countries United States
Sponsor Memorial Sloan Kettering Cancer Center
Condition Anxiety, Depression Recruiting NCT07186309
This study is recruiting in the United States. It is testing a Test for depression.
Remote / online Depression Device Over 18 Years
Countries United States
Sponsor University of Virginia
Condition Depression 
